0.2845USD+255.63%Mkt Cap: —P/E: —1d ago
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan…
Industry Peers
Financial ServicesKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)38.46M $
Gross Profit18.36M $
Net Income (TTM)-64.78M $
Revenue/Share0.3080 USD
Last Price0.2845 USD
Fiscal Year End—
MR Quarter—
Employees89
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.16
EPS (TTM)—
EPS (Forward)—
52W Range
0.079393% of range0.3000
52W High0.3000 USD
52W Low0.0793 USD
Profitability
Gross Margin98.38%
Oper. Margin-49.47%
EBITDA Margin-56.16%
Profit Margin-347.04%
ROE-24.26%
ROA-21.53%
Growth
Revenue Growth244.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.45M $
CapEx (TTM)565.00K $
FCF Margin-0.74%
FCF Yield—
Net Debt-33.08M $
Net Debt/EBITDA1.53
Balance Sheet
Debt/Equity0.08
Current Ratio4.80
Quick Ratio4.53
Book Value/Sh1.790 USD
Cash/Share0.3580 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float118.24M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.22
S&P 52W Chg18.16%
Avg Vol (30d)1.34K
Avg Vol (10d)—
Technical Indicators
RSI (14)95.9
MACD0.0141
MACD Signal0.0023
MACD Hist.+0.0118
BB Upper0.1862 USD
BB Middle0.0982 USD
BB Lower0.0103 USD
BB Width179.13%
ATR (14)0.0164 USD
Vol Ratio (20d)933.87x